Corrigendum to Amyotrophic lateral sclerosis-related VAPB P56S mutation differentially affects the function and survival of corticospinal and spinal motor neurons [Human Molecular Genetics, 22, 21, (2013) 4293-4305] DOI: 10.1093/hmg/ddt279;Amyotrophic lateral sclerosis-related VAPB P56S mutation differentially affects the function and survival of corticospinal and spinal motor neurons

Human Molecular Genetics

Volumn 22, Issue 21, 2013, Pages 4293-4305

  Aliaga, Leonardo ^a   Lai, Chen ^a   Yu, Jia ^a   Chub, Nikolai ^b   Shim, Hoon ^a   Sun, Lixin ^a   Xie, Chengsong ^a   Yang, Wan Jou ^a   Lin, Xian ^a   O'Donovan, Michael J ^b   Cai, Huaibin ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; MESSENGER RNA; SYNAPTOBREVIN; UNCLASSIFIED DRUG; VESICLE ASSOCIATED MEMBRANE PROTEIN B;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL FUNCTION; CELL SURVIVAL; CONTROLLED STUDY; DENDRITE; ENDOPLASMIC RETICULUM STRESS; HETEROLOGOUS EXPRESSION; HUMAN; HYPERACTIVITY; LOCOMOTION; MALE; MISSENSE MUTATION; MOLECULAR PATHOLOGY; MOUSE; NERVE CELL DEGENERATION; NONHUMAN; PHENOTYPE; POSTSYNAPTIC MEMBRANE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN STABILITY; PROTEIN TRANSPORT; PYRAMIDAL NERVE CELL; SPINAL CORD MOTONEURON; TRANSGENIC MOUSE; UNFOLDED PROTEIN RESPONSE; UPREGULATION; WILD TYPE;

MUS;

AMINO ACID SUBSTITUTION; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CELL SURVIVAL; DENDRITES; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOTOR ACTIVITY; MOTOR NEURONS; MUTATION, MISSENSE; NERVE DEGENERATION; PRESYNAPTIC TERMINALS; PROLINE; SERINE; SPINAL CORD; UNFOLDED PROTEIN RESPONSE; VESICULAR TRANSPORT PROTEINS;

EID: 84885734944     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddu098     Document Type: Erratum

References (36)

1. Nishimura, A.L., Mitne-Neto, M., Silva, H.C., Richieri-Costa, A., Middleton, S., Cascio, D., Kok, F., Oliveira, J.R., Gillingwater, T., Webb, J. et al. (2004) A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am. J. Hum. Genet., 75, 822-831.
2. Marques, V.D., Barreira, A.A., Davis, M.B., Abou-Sleiman, P.M., Silva, W.A. Jr, Zago, M.A., Sobreira, C., Fazan, V. and Marques, W. Jr. (2006) Expanding the phenotypes of the Pro56Ser VAPB mutation: proximalSMA with dysautonomia. Muscle Nerve, 34, 731-739.
3. Ackerman, S.L. and Cox, G.A. (2008) From ER to Eph receptors: new roles for VAP fragments. Cell, 133, 949-951.
4. Nishimura, Y., Hayashi, M., Inada, H. and Tanaka, T. (1999) Molecular cloning and characterization of mammalian homologues of vesicle-associated membrane protein-associated (VAMP-associated) proteins. Biochem. Biophys. Res. Commun., 254, 21-26.
5. Tsuda, H., Han, S.M., Yang, Y., Tong, C., Lin, Y.Q., Mohan, K., Haueter, C., Zoghbi, A., Harati, Y., Kwan, J. et al. (2008) The amyotrophic lateral sclerosis 8 protein VAPB is cleaved, secreted, and acts as a ligand for Eph receptors. Cell, 133, 963-977.
6. Amarilio, R., Ramachandran, S., Sabanay, H. and Lev, S. (2005) Differential regulation of endoplasmic reticulum structure through VAP-Nir protein interaction. J. Biol. Chem., 280, 5934-5944.
7. Kanekura, K., Nishimoto, I., Aiso, S. and Matsuoka, M. (2006) Characterization of amyotrophic lateral sclerosis-linked P56S mutation of vesicle-associated membrane protein-associated protein B (VAPB/ALS8). J. Biol. Chem., 281, 30223-30233.
8. Gkogkas, C., Middleton, S., Kremer, A.M., Wardrope, C., Hannah, M., Gillingwater, T.H. and Skehel, P. (2008)VAPBinteracts with and modulates the activity of ATF6. Hum. Mol. Genet., 17, 1517-1526.
9. Suzuki, H., Kanekura, K., Levine, T.P., Kohno, K., Olkkonen, V.M., Aiso, S. and Matsuoka, M. (2009) ALS-linked P56S-VAPB, an aggregated loss-of-function mutant of VAPB, predisposes motor neurons to ER stress-related death by inducing aggregation of co-expressed wild-type VAPB. J. Neurochem., 108, 973-985.
10. Fasana, E., Fossati, M., Ruggiano, A., Brambillasca, S., Hoogenraad, C.C., Navone, F., Francolini, M. and Borgese, N. (2009)AVAPBmutant linked to amyotrophic lateral sclerosis generates a novel form of organized smooth endoplasmic reticulum. FASEB J., 24, 1419-1430.
11. De Vos, K.J., Morotz, G.M., Stoica, R., Tudor, E.L., Lau, K.F., Ackerley, S., Warley, A., Shaw, C.E. and Miller, C.C. (2012) VAPB interacts with the mitochondrial protein PTPIP51 to regulate calcium homeostasis. Hum. Mol. Genet., 21, 1299-1311.
12. Han, S.M., Tsuda, H., Yang, Y., Vibbert, J., Cottee, P., Lee, S.J., Winek, J., Haueter, C., Bellen, H.J. and Miller, M.A. (2012) Secreted VAPB/ALS8 major sperm protein domains modulate mitochondrial localization and morphology via growth cone guidance receptors. Dev. Cell, 22, 348-362.
13. Tran, D., Chalhoub, A., Schooley, A., Zhang, W. and Ngsee, J.K. (2012) A mutation in VAPB that causes amyotrophic lateral sclerosis also causes a nuclear envelope defect. J. Cell Sci., 125, 2831-2836.
14. Tudor, E.L., Galtrey, C.M., Perkinton, M.S., Lau, K.F., De Vos, K.J., Mitchell, J.C., Ackerley, S., Hortobagyi, T., Vamos, E., Leigh, P.N. et al. (2010) Amyotrophic lateral sclerosis mutant vesicle-associated membrane protein-associated protein-B transgenic mice develop TAR-DNA-binding protein-43 pathology. Neuroscience, 167, 774-785.
15. Qiu, L., Qiao, T., Beers, M., Tan, W., Wang, H., Yang, B. and Xu, Z. (2013) Widespread aggregation of mutant VAPB associated with ALS does not cause motor neuron degeneration or modulate mutantSOD1aggregation and toxicity in mice. Mol. Neurodegener., 8, 1.
16. LaMonte, B.H., Wallace, K.E., Holloway, B.A., Shelly, S.S., Ascano, J., Tokito, M., Van Winkle, T., Howland, D.S. and Holzbaur, E.L. (2002) Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron, 34, 715-727.
17. Arlotta, P., Molyneaux, B.J., Chen, J., Inoue, J., Kominami, R. and Macklis, J.D. (2005) Neuronal subtype-specific genes that control corticospinal motor neuron development in vivo. Neuron, 45, 207-221.
18. Moumen, A., Virard, I. and Raoul, C. (2011) Accumulation of wildtype and ALS-linked mutated VAPB impairs activity of the proteasome. PLoS ONE, 6, e26066.
19. Wooley, C.M., Sher, R.B., Kale, A., Frankel, W.N., Cox, G.A. and Seburn, K.L. (2005) Gait analysis detects early changes in transgenic SOD1(G93A) mice. Muscle Nerve, 32, 43-50.
20. Lai, C., Lin, X., Chandran, J., Shim, H., Yang, W.J. and Cai, H. (2007) The G59S mutation in p150(glued) causes dysfunction of dynactin in mice. J. Neurosci., 27, 13982-13990.
21. Bernales, S., Papa, F.R. and Walter, P. (2006) Intracellular signaling by the unfolded protein response. Annu. Rev. Cell Dev. Biol., 22, 487-508.
22. Bertolotti, A., Zhang, Y., Hendershot, L.M., Harding, H.P. and Ron, D. (2000) Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat. Cell Biol., 2, 326-332.
23. Todd, D.J., Lee, A.H. and Glimcher, L.H. (2008) The endoplasmic reticulum stress response in immunity and autoimmunity. Nat. Rev. Immunol., 8, 663-674.
24. Wang, L., Popko, B. and Roos, R.P. (2011) The unfolded protein response in familial amyotrophic lateral sclerosis. Hum. Mol. Genet., 20, 1008-1015.
25. Molyneaux, B.J., Arlotta, P. and Macklis, J.D. (2007) Molecular development of corticospinal motor neuron circuitry. Novartis. Found. Symp., 288, 3-15.
26. Ince, P.G., Slade, J., Chinnery, R.M., McKenzie, J., Royston, C., Roberts, G.W. and Shaw, P.J. (1995) Quantitative study of synaptophysin immunoreactivity of cerebral cortex and spinal cord in motor neuron disease. J. Neuropathol. Exp. Neurol., 54, 673-679.
27. Hellstrom, J., Oliveira, A.L., Meister, B. and Cullheim, S. (2003) Large cholinergic nerve terminals on subsets of motoneurons and their relation to muscarinic receptor type 2. J. Comp Neurol., 460, 476-486.
28. Miles, G.B., Hartley, R., Todd, A.J. and Brownstone, R.M. (2007) Spinal cholinergic interneurons regulate the excitability of motoneurons during locomotion. Proc. Natl Acad. Sci. USA, 104, 2448-2453.
29. Zagoraiou, L., Akay, T., Martin, J.F., Brownstone, R.M., Jessell, T.M. and Miles, G.B. (2009)Acluster of cholinergic premotor interneurons modulates mouse locomotor activity. Neuron, 64, 645-662.
30. Lin, X., Parisiadou, L., Gu, X.L., Wang, L., Shim, H., Sun, L., Xie, C., Long, C.X., Yang, W.J., Ding, J. et al. (2009) Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant alpha-synuclein. Neuron, 64, 807-827.
31. Chen, B., Schaevitz, L.R. and McConnell, S.K. (2005) Fezl regulates the differentiation and axon targeting of layer 5 subcortical projection neurons in cerebral cortex. Proc. Natl Acad. Sci. USA, 102, 17184-17189.
32. Yang, H.W. and Lemon, R.N. (2003) An electron microscopic examination of the corticospinal projection to the cervical spinal cord in the rat: lack of evidence for cortico-motoneuronal synapses. Exp. Brain Res., 149, 458-469.
33. Cai, H., Lin, X., Xie, C., Laird, F.M., Lai, C., Wen, H., Chiang, H.C., Shim, H., Farah, M.H., Hoke, A. et al. (2005) Loss of ALS2 function is insufficient to trigger motor neuron degeneration in knock-out mice but predisposes neurons to oxidative stress. J. Neurosci., 25, 7567-7574.
34. Chandran, J.S., Lin, X., Zapata, A., Hoke, A., Shimoji, M., Moore, S.O., Galloway, M.P., Laird, F.M., Wong, P.C., Price, D.L. et al. (2008) Progressive behavioral deficits in DJ-1-deficient mice are associated with normal nigrostriatal function. Neurobiol. Dis., 29, 505-514.
35. Tao-Cheng, J.H., Gallant, P.E., Brightman, M.W., Dosemeci, A. and Reese, T.S. (2007) Structural changes at synapses after delayed perfusion fixation in different regions of the mouse brain. J. Comp. Neurol., 501, 731-740.
36. Bonnot, A., Chub, N., Pujala, A. and O'Donovan, M.J. (2009) Excitatory actions of ventral root stimulation during network activity generated by the disinhibited neonatal mouse spinal cord. J. Neurophysiol., 101, 2995-3011.